Outer Membrane Proteins and Efflux Pumps Mediated Multi-Drug Resistance in Salmonella: Rising Threat to Antimicrobial Therapy
Despite colossal achievements in antibiotic therapy in recent decades, drug-resistant
pathogens have remained a leading cause of death and economic loss globally. One such …
pathogens have remained a leading cause of death and economic loss globally. One such …
In Vitro Microevolution and Co-Selection Assessment of Florfenicol Impact on Escherichia coli Resistance Development
The issue of antimicrobial resistance is becoming an increasingly serious challenge in both
human and veterinary medicine. Prudent antimicrobial use in veterinary medicine is …
human and veterinary medicine. Prudent antimicrobial use in veterinary medicine is …
Metabolic Engineering of Escherichia coli for High-Level Production of l-Phenylalanine
X Wang, C Qiu, C Chen, C Gao, W Wei… - Journal of Agricultural …, 2024 - ACS Publications
l-Phenylalanine (l-Phe) is widely used in the food and pharmaceutical industries. However,
the biosynthesis of l-Phe using Escherichia coli remains challenging due to its lower …
the biosynthesis of l-Phe using Escherichia coli remains challenging due to its lower …
Antibiotic resistant bacteria survive treatment by doubling while shrinking
Many antibiotics that are used in healthcare, farming, and aquaculture end up in
environments with different spatial structures that might promote heterogeneity in the …
environments with different spatial structures that might promote heterogeneity in the …
Suppressors of lapC Mutation Identify New Regulators of LpxC, Which Mediates the First Committed Step in Lipopolysaccharide Biosynthesis
A Maniyeri, A Wieczorek, A Ayyolath… - International Journal of …, 2023 - mdpi.com
Gram-negative bacteria, such as Escherichia coli, are characterized by an asymmetric outer
membrane (OM) with lipopolysaccharide (LPS) located in the outer leaflet and …
membrane (OM) with lipopolysaccharide (LPS) located in the outer leaflet and …
Antibiotics do not induce expression of acrAB directly but via a RamA-dependent pathway
V Ricci, J Kaur, J Stone… - Antimicrobial Agents and …, 2023 - Am Soc Microbiol
The aim of this study was to determine if acrAB induction in Salmonella Typhimurium relies
solely on RamA or if other transcriptional activator pathways are also involved, and to better …
solely on RamA or if other transcriptional activator pathways are also involved, and to better …
Tazobactam selects for multidrug resistance
Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination which is amongst
the most prescribed antimicrobials in hospital medicine. Piperacillin is inactivated by …
the most prescribed antimicrobials in hospital medicine. Piperacillin is inactivated by …
[HTML][HTML] Microbial musings: winter 2023
A Preston - Microbiology, 2023 - ncbi.nlm.nih.gov
This is the first edition of Microbial Musings since Microbiology moved to a fully open access
(OA) format, so this may be the first time you are reading Musings. Here, editors highlight …
(OA) format, so this may be the first time you are reading Musings. Here, editors highlight …
Special collection to commemorate 40 years of antimicrobial efflux
To mark the 40 year anniversary of the seminal description of antibiotic efflux pumps in
bacteria [1] and the 30 year milestone of the characterization of the resistance-nodulation …
bacteria [1] and the 30 year milestone of the characterization of the resistance-nodulation …
Scalable and Chromatography‐Free Synthesis of Efflux Pump Inhibitor Phenylalanine Arginine β‐Naphthylamide for Its Validation in Wild‐Type Bacterial Strains
CM Russo, KG Howey, MC O'Reilly - ChemMedChem, 2023 - Wiley Online Library
Phenylalanine arginine β‐naphthylamine, or PAβN, is a C‐terminus capped dipeptide
discovered in 1999 as an RND‐type efflux pump inhibitor (EPI). Since then, PAβN has …
discovered in 1999 as an RND‐type efflux pump inhibitor (EPI). Since then, PAβN has …